D-0391-2025 Class II Ongoing
FDA drug recall D-0391-2025 was initiated by Preferred Pharmaceuticals, Inc. on Apr 18, 2025 and is designated Class II. Reason for recall: cGMP Deviations The recall status is ongoing. Affected quantity: 1190 Bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- May 7, 2025
- Initiation Date
- Apr 18, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1190 Bottles
Product Description
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Reason for Recall
cGMP Deviations
Distribution Pattern
Nationwide in the US
Code Information
Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0391-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026